260 related articles for article (PubMed ID: 809457)
21. Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity.
Saeed uz Zafar M; Mellinger RC; Fine G; Szabo M; Frohman LA
J Clin Endocrinol Metab; 1979 Jan; 48(1):66-71. PubMed ID: 422708
[TBL] [Abstract][Full Text] [Related]
22. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
23. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
[TBL] [Abstract][Full Text] [Related]
24. Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.
Nakagawa K; Obara T
J Clin Endocrinol Metab; 1977 Jan; 44(1):189-93. PubMed ID: 401823
[TBL] [Abstract][Full Text] [Related]
25. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
26. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
Hanew K; Aida M; Tano T; Yoshinaga K
Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
[TBL] [Abstract][Full Text] [Related]
27. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
28. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
29. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
[TBL] [Abstract][Full Text] [Related]
30. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
Samaan NA; Leavens ME; Jesse RH
J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
[No Abstract] [Full Text] [Related]
31. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
[TBL] [Abstract][Full Text] [Related]
32. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology.
Cunningham GR; Huckins C
J Clin Endocrinol Metab; 1977 Feb; 44(2):248-53. PubMed ID: 402377
[TBL] [Abstract][Full Text] [Related]
33. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
34. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
Levitt NS; Ratanjee BD; Abrahamson MJ
Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acromegaly by transsphenoidal microsurgery.
Giovanelli MA; Motti ED; Paracchi A; Beck-Peccoz P; Ambrosi B; Faglia G
J Neurosurg; 1976 Jun; 44(6):677-86. PubMed ID: 818343
[TBL] [Abstract][Full Text] [Related]
36. The results of transsphenoidal surgery for 44 consecutive acromegalic patients.
Yamada S; Takada K; Ozawa Y; Shimizu T; Sawano S; Shishiba Y; Sano T; Usui M
Endocr J; 1997 Jun; 44(3):395-402. PubMed ID: 9279515
[TBL] [Abstract][Full Text] [Related]
37. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
Candrina R
Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
[TBL] [Abstract][Full Text] [Related]
38. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
39. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
[TBL] [Abstract][Full Text] [Related]
40. The natural course of growth hormone-secreting pituitary adenomas after surgery alone--clinical significance of the growth hormone response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone.
Mukada K
Neurol Med Chir (Tokyo); 1990 Apr; 30(4):251-7. PubMed ID: 1696695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
